Compare · Research-Use-Only
Epithalon vs NAD+
Two compounds that appear together in longevity research discussion but sit at opposite ends of the evidence spectrum. Epithalon is a synthetic tetrapeptide studied for telomerase induction, with a literature that is small and largely from a single research group. NAD+ is a fundamental redox cofactor and consumed substrate for sirtuins, PARPs and CD38, with a very large and independent body of work.
Epithalon
Epithalon is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, whose sequence was derived from the amino acid composition of Epithalamin, a bovine pineal gland extract. Distinguishing the two is essential when reading this literature: Epithalamin is a complex peptide extract, whereas Epithalon is a defined synthetic tetrapeptide, and the two have largely separate evidence bases. The most-cited proposed mechanism is telomere-related — addition of Epithalon to telomerase-negative human fetal fibroblast cultures was reported to induce expression of the telomerase catalytic subunit, enzymatic telomerase activity, and telomere elongation, with a follow-up reporting that treated fibroblasts underwent approximately ten additional passages beyond the control replicative limit. A 2025 independent study reported dose-dependent telomere elongation in normal epithelial and fibroblast cells via hTERT and telomerase upregulation, and telomere extension in breast cancer cell lines via the Alternative Lengthening of Telomeres pathway, the ALT contribution being largely cancer-cell-specific; note that this paper carries a published correction. A second proposed mechanism involves direct interaction with nucleic acids, with reports that short regulatory peptides bind the DNA double helix and modulate gene transcription, though structural and biophysical characterization of this interaction remains limited. In rodent models, Epithalon has been reported to reduce chromosome aberration frequency in bone marrow cells and to downregulate HER-2/neu transcript expression in mammary tumors of transgenic mice. Importantly, the frequently asserted claim that Epithalon restores melatonin secretion is not supported by direct measurement: an independent perifusion study found that Ala-Glu-Asp-Gly had no significant effect on melatonin secretion by pineal glands from either young or old rats, and did not modify stimulated melatonin release. The overall mechanistic picture remains poorly resolved.
NAD+
NAD+ is an obligate redox cofactor that cycles between oxidized and reduced states, accepting a hydride at the C4 position of its nicotinamide ring. In this capacity it is the principal electron carrier for glycolysis, the tricarboxylic acid cycle and fatty acid beta-oxidation, delivering reducing equivalents to complex I of the mitochondrial electron transport chain. Separately from redox cycling, NAD+ is consumed stoichiometrically as a substrate by three enzyme families that cleave the glycosidic bond and release nicotinamide: the sirtuin NAD+-dependent protein deacylases, the poly(ADP-ribose) polymerases, and the NAD+ glycohydrolases CD38 and CD157, together with SARM1 in axonal degeneration. Because these enzymes destroy NAD+ rather than recycle it, cellular NAD+ must be continuously resynthesized. Mammalian cells regenerate NAD+ mainly through the salvage pathway, in which nicotinamide phosphoribosyltransferase — the rate-limiting step — converts nicotinamide to nicotinamide mononucleotide, which adenylyltransferases convert to NAD+ in distinct subcellular compartments. Two additional routes contribute: de novo synthesis from tryptophan via the kynurenine pathway, and the Preiss-Handler pathway from nicotinic acid. The core preclinical hypothesis under investigation is that tissue NAD+ availability declines with age and metabolic stress, partly through increased consumption and reduced salvage activity, and that raising NAD+ with precursors restores sirtuin and mitochondrial function; the extent to which this translates to clinical benefit in humans remains unresolved, and the best-controlled trials to date have produced null results on functional endpoints.
Other research peptide comparisons
Both compounds in stock at Veridian. 99%+ HPLC purity, same-day US shipping.
Browse all research peptides →